Early allograft dysfunction after liver transplantation

A definition and predictors of outcome

Marc Deschênes, Steven H. Belle, Ruud A F Krom, Rowen K Zetterman, John R. Lake

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

Background. Poor graft function early after liver transplantation is an important cause of morbidity and mortality. We defined early allograft dysfunction (EAD) using readily available indices of function and identified donor, graft, and pretransplant recipient factors associated with this outcome. Methods. This study examined 710 adult recipients of a first, single-organ liver transplantation for non-fulminant liver disease at three United States centers. EAD was defined by the presence of at least one of the following between 2 and 7 days after liver transplantation: serum bilirubin >10 mg/dl, prothrombin time (PT) ≤17 sec, and hepatic encephalopathy. Results. EAD incidence was 23%. Median intensive care unit (ICU) and hospital stays were longer for recipients with EAD than those without (4 days vs. 3 days, P=0.0001; 24 vs. 15 days, P=0.0001, respectively). Three-year recipient and graft survival were worse in those with EAD than in those without (68% vs. 83%, P=0.0001; 61% vs. 79%, P=0.0001). A logistic regression model combining donor, graft, and recipient factors predicted EAD better than models examining these factors in isolation. Pretransplant recipient elevations in PT and bilirubin, awaiting a graft in hospital or ICU, donor age ≤50 years, donor hospital stay >3 days, preprocurement acidosis, and cold ischemia time ≤15 hr were independently associated with EAD. Conclusion. Recipients who develop EAD have longer ICU and hospital stays and greater mortality than those without. Donor, graft, and recipient risk factors all contribute to the development of EAD. Resuits of these analyses identify factors that, if modified, may alter the risk of EAD.

Original languageEnglish (US)
Pages (from-to)302-310
Number of pages9
JournalTransplantation
Volume66
Issue number3
StatePublished - Aug 15 1998

Fingerprint

Liver Transplantation
Allografts
Transplants
Intensive Care Units
Length of Stay
Prothrombin Time
Bilirubin
Logistic Models
Cold Ischemia
Hepatic Encephalopathy
Mortality
Organ Transplantation
Graft Survival
Acidosis
Statistical Factor Analysis
Liver Diseases
Morbidity
Incidence
Serum

ASJC Scopus subject areas

  • Transplantation

Cite this

Deschênes, M., Belle, S. H., Krom, R. A. F., Zetterman, R. K., & Lake, J. R. (1998). Early allograft dysfunction after liver transplantation: A definition and predictors of outcome. Transplantation, 66(3), 302-310.

Early allograft dysfunction after liver transplantation : A definition and predictors of outcome. / Deschênes, Marc; Belle, Steven H.; Krom, Ruud A F; Zetterman, Rowen K; Lake, John R.

In: Transplantation, Vol. 66, No. 3, 15.08.1998, p. 302-310.

Research output: Contribution to journalArticle

Deschênes, M, Belle, SH, Krom, RAF, Zetterman, RK & Lake, JR 1998, 'Early allograft dysfunction after liver transplantation: A definition and predictors of outcome', Transplantation, vol. 66, no. 3, pp. 302-310.
Deschênes, Marc ; Belle, Steven H. ; Krom, Ruud A F ; Zetterman, Rowen K ; Lake, John R. / Early allograft dysfunction after liver transplantation : A definition and predictors of outcome. In: Transplantation. 1998 ; Vol. 66, No. 3. pp. 302-310.
@article{a43edaa580da4e5cac7043298f5e6fb5,
title = "Early allograft dysfunction after liver transplantation: A definition and predictors of outcome",
abstract = "Background. Poor graft function early after liver transplantation is an important cause of morbidity and mortality. We defined early allograft dysfunction (EAD) using readily available indices of function and identified donor, graft, and pretransplant recipient factors associated with this outcome. Methods. This study examined 710 adult recipients of a first, single-organ liver transplantation for non-fulminant liver disease at three United States centers. EAD was defined by the presence of at least one of the following between 2 and 7 days after liver transplantation: serum bilirubin >10 mg/dl, prothrombin time (PT) ≤17 sec, and hepatic encephalopathy. Results. EAD incidence was 23{\%}. Median intensive care unit (ICU) and hospital stays were longer for recipients with EAD than those without (4 days vs. 3 days, P=0.0001; 24 vs. 15 days, P=0.0001, respectively). Three-year recipient and graft survival were worse in those with EAD than in those without (68{\%} vs. 83{\%}, P=0.0001; 61{\%} vs. 79{\%}, P=0.0001). A logistic regression model combining donor, graft, and recipient factors predicted EAD better than models examining these factors in isolation. Pretransplant recipient elevations in PT and bilirubin, awaiting a graft in hospital or ICU, donor age ≤50 years, donor hospital stay >3 days, preprocurement acidosis, and cold ischemia time ≤15 hr were independently associated with EAD. Conclusion. Recipients who develop EAD have longer ICU and hospital stays and greater mortality than those without. Donor, graft, and recipient risk factors all contribute to the development of EAD. Resuits of these analyses identify factors that, if modified, may alter the risk of EAD.",
author = "Marc Desch{\^e}nes and Belle, {Steven H.} and Krom, {Ruud A F} and Zetterman, {Rowen K} and Lake, {John R.}",
year = "1998",
month = "8",
day = "15",
language = "English (US)",
volume = "66",
pages = "302--310",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Early allograft dysfunction after liver transplantation

T2 - A definition and predictors of outcome

AU - Deschênes, Marc

AU - Belle, Steven H.

AU - Krom, Ruud A F

AU - Zetterman, Rowen K

AU - Lake, John R.

PY - 1998/8/15

Y1 - 1998/8/15

N2 - Background. Poor graft function early after liver transplantation is an important cause of morbidity and mortality. We defined early allograft dysfunction (EAD) using readily available indices of function and identified donor, graft, and pretransplant recipient factors associated with this outcome. Methods. This study examined 710 adult recipients of a first, single-organ liver transplantation for non-fulminant liver disease at three United States centers. EAD was defined by the presence of at least one of the following between 2 and 7 days after liver transplantation: serum bilirubin >10 mg/dl, prothrombin time (PT) ≤17 sec, and hepatic encephalopathy. Results. EAD incidence was 23%. Median intensive care unit (ICU) and hospital stays were longer for recipients with EAD than those without (4 days vs. 3 days, P=0.0001; 24 vs. 15 days, P=0.0001, respectively). Three-year recipient and graft survival were worse in those with EAD than in those without (68% vs. 83%, P=0.0001; 61% vs. 79%, P=0.0001). A logistic regression model combining donor, graft, and recipient factors predicted EAD better than models examining these factors in isolation. Pretransplant recipient elevations in PT and bilirubin, awaiting a graft in hospital or ICU, donor age ≤50 years, donor hospital stay >3 days, preprocurement acidosis, and cold ischemia time ≤15 hr were independently associated with EAD. Conclusion. Recipients who develop EAD have longer ICU and hospital stays and greater mortality than those without. Donor, graft, and recipient risk factors all contribute to the development of EAD. Resuits of these analyses identify factors that, if modified, may alter the risk of EAD.

AB - Background. Poor graft function early after liver transplantation is an important cause of morbidity and mortality. We defined early allograft dysfunction (EAD) using readily available indices of function and identified donor, graft, and pretransplant recipient factors associated with this outcome. Methods. This study examined 710 adult recipients of a first, single-organ liver transplantation for non-fulminant liver disease at three United States centers. EAD was defined by the presence of at least one of the following between 2 and 7 days after liver transplantation: serum bilirubin >10 mg/dl, prothrombin time (PT) ≤17 sec, and hepatic encephalopathy. Results. EAD incidence was 23%. Median intensive care unit (ICU) and hospital stays were longer for recipients with EAD than those without (4 days vs. 3 days, P=0.0001; 24 vs. 15 days, P=0.0001, respectively). Three-year recipient and graft survival were worse in those with EAD than in those without (68% vs. 83%, P=0.0001; 61% vs. 79%, P=0.0001). A logistic regression model combining donor, graft, and recipient factors predicted EAD better than models examining these factors in isolation. Pretransplant recipient elevations in PT and bilirubin, awaiting a graft in hospital or ICU, donor age ≤50 years, donor hospital stay >3 days, preprocurement acidosis, and cold ischemia time ≤15 hr were independently associated with EAD. Conclusion. Recipients who develop EAD have longer ICU and hospital stays and greater mortality than those without. Donor, graft, and recipient risk factors all contribute to the development of EAD. Resuits of these analyses identify factors that, if modified, may alter the risk of EAD.

UR - http://www.scopus.com/inward/record.url?scp=0345647100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345647100&partnerID=8YFLogxK

M3 - Article

VL - 66

SP - 302

EP - 310

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 3

ER -